Skip to main content
. Author manuscript; available in PMC: 2014 Feb 23.
Published in final edited form as: CNS Oncol. 2013 Jan;2(1):33–47. doi: 10.2217/cns.12.29

Figure 6. 18F-fluorodeoxyglucose PET uptake at recurrence after antiangiogenic therapy.

Figure 6

18F-FDG PET–MR fusion images show co-localization of elevated 18F-FDG in the medial contrast-enhancing nodule. 18F-FDG PET uptake images show elevated 18F-FDG uptake within the tumor areas.

18F-FDG: 18F-fluorodeoxyglucose; MR: Magnetic resonance; SUV: Standardized uptake value.